Trial Profile
An open-label, non-controlled study to immunize healthy volunteers actively working with or in the vicinity of replicating Vaccinia virus with IMVAMUNE (MVA-BN)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Pharmacodynamics; Therapeutic Use
- 22 Jun 2011 New trial record